Major regulatory validation; merger and acquisitions appeal; supports global regulatory strategy; top tier milestone 💪
FDA Grants Fast Track Designation to Incannex Healthcare for IHL-42X in Obstructive Sleep Apnea
Incannex Healthcare Inc. announced that the U.S. Food and Drug Administration has granted Fast Track designation for its oral fixed-dose combination product candidate, IHL-42X, for the treatment of obstructive sleep apnea . The designation was based on promising results from three clinical trials, including a Phase 2 study that showed significant reductions in Apnea-Hypopnea Index and strong patient-reported outcomes. Fast Track status enables Incannex to benefit from more frequent interactions with the FDA, eligibility for rolling review, and potential access to Accelerated Approval and Priority Review, subject to meeting relevant criteria. No other organizations were mentioned as recipients of this grant or regulatory designation.Disclaimer: This news brief was created by Public Technologies using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpret
Earnings Preview | Grab's Q3 EPS Has Room for Improvement
Summary: Southeast Asian ride-hailing and food delivery giant $Grab Holdings(GRAB)$ will release its third-quarter earnings after the U.S. market closes on November 3.Q2 ReviewIn Q2 2025, Grab's mon
They need to make options tradable outside the standard hours as well
Nasdaq Joins Exchanges Seeking to Offer Round-the-Clock Trading
Nasdaq Inc. plans to offer 24-hour trading on its equities exchange, the latest venue seeking to capitalize on growing global demand for US stocks.The second-largest US exchange operator plans to enab